CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Phase III Multicenter Trial of Doxorubicin Plus Cyclophosphamide Followed by Paclitaxel Compared With Doxorubicin Plus Paclitaxel Followed by Weekly Paclitaxel As Adjuvant Therapy for Women With High-Risk Breast Cancer
Authors
Berry D
David Loesch
+26Â more
Deborah Lindquist
F. Anthony Greco
Feng Zhan
Frankie Holmes
Gianni L
Gianni L
Giordano SH
Henderson IC
Howard A. Burris
Jaspers JE
Joanne L. Blum
John D. Hainsworth
John Pippen
John Sandbach
Kristi A. Boehm
Kristi McIntyre
Lina Asmar
Manuel R. Modiano
Neil N. Senzer
Nicholas Robert
Norton L
Ocean AJ
Pouillart P
Scot Sedlacek
Stephen Jones
Svetislava J. Vukelja
Publication date
Publisher
'American Society of Clinical Oncology (ASCO)'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 25/10/2020